✦ LIBER ✦

Long-term trial with the oral iron chelator 1,2-dimethy1-3-hydroxypyrid-4-one (L1) II. CLINICAL OBSERVATIONS

✍ Scribed by A. N. Bartlett; A. V. Hoffbrand; G. J. Kontoghiorghes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term trial with the oral iron chela

✍ G. J. Kontoghiorghes; A. N. Bartlett; A. V. Hoffbrand; J. G. Goddard; L. Sheppar 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

Long-term treatment of transfusional iro

✍ M.J. Kersten; R. Lange; M.E.P. Smeets; G. Vreugdenhil; R. Goudsmit; K.J. Roozend 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Evaluation of the Oral Iron Chelator 1,2

✍ NANCY F. OLIVIERI; DOUGLAS M. TEMPLETON; GIDEON KOREN; DEREK CHUNG; CHRISTINE HE 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

Pharmacokinetic studies in humans with t

✍ Kontoghiorghes, George J; Goddard, J Graham; Bartlett, Arudanthy N; Sheppard, Ly 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 531 KB

L1 (1,2-dimethyl-3-hydroxypyrid-4-one) f

✍ Petrin Toundury; George J. Kontoghiorghes; Annette Ridolfi-Luuthy; Andreas Hirt; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB

Long-term treatment of transfusional iro

✍ M. J. Kersten; R. Lange; M. E. P. Smeets; G. Vreugdenhil; K. J. Roozendaal; W. L 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 195 KB